Skip Navigation

International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

Brief Summary

Type:
Multiple Sites (Solid Tumors)

Study Type:
Treatment

Phase:
II/III

ClinicalTrials.gov Identifier:
NCT02205762

Study #:
cmh - LCHIV

Start Date:
Nov 21, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02205762

View Complete Trial Details & Eligibility at ClinicalTrials.gov